Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 20100958

Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 Feb 20
First author
Khambata-Ford S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Aug 10;28(23):e393; author reply e394-6. doi: 10.1200/JCO.2010.28.7342.
    note
    Source null
    related pmid
    20547983
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2010 Sep 20;28(27):e467; author reply e468. doi: 10.1200/JCO.2010.28.5973.
    note
    Source null
    related pmid
    20585086
    relationship
    Comment in

Authors and identifiers

  1. name
    Khambata-Ford S
    type
    Author
  2. name
    Harbison CT
    type
    Author
  3. name
    Hart LL
    type
    Author
  4. name
    Awad M
    type
    Author
  5. name
    Xu LA
    type
    Author
  6. name
    Horak CE
    type
    Author
  7. name
    Dakhil S
    type
    Author
  8. name
    Hermann RC
    type
    Author
  9. name
    Lynch TJ
    type
    Author
  10. name
    Weber MR
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Khambata-Ford S
    type
    Author
  2. name
    Harbison CT
    type
    Author
  3. name
    Hart LL
    type
    Author
  4. name
    Awad M
    type
    Author
  5. name
    Xu LA
    type
    Author
  6. name
    Horak CE
    type
    Author
  7. name
    Dakhil S
    type
    Author
  8. name
    Hermann RC
    type
    Author
  9. name
    Lynch TJ
    type
    Author
  10. name
    Weber MR
    type
    Author
bibliography ids
  1. nci-bib-acb06b8939f60e963fc87802
book metadata
content sha256
6f2e1c866fe2707d44c4950224e8df5824d8871ae1690bc12fe35f0fae6a5500
document type
citation
dois
  1. 10.1200/JCO.2009.25.2890
electronic publication date
display
2010 Jan 25
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20100958
immutable id
pubmed:20100958@6f2e1c866fe2707d44c4950224e8df5824d8871ae1690bc12fe35f0fae6a5500
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
6
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
918-27
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Aug 10;28(23):e393; author reply e394-6. doi: 10.1200/JCO.2010.28.7342.
    note
    Source null
    related pmid
    20547983
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2010 Sep 20;28(27):e467; author reply e468. doi: 10.1200/JCO.2010.28.5973.
    note
    Source null
    related pmid
    20585086
    relationship
    Comment in
outcomes validated
false
pmid
20100958
provenance
batch id
708c7929ee1eff455330
provider
NCBI PubMed ESummary
record sha256
4bdf784dbe8f81bf3fa2c425dbf5f18e280083800719ed1154cef26fcbc6ec01
response sha256
d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
retrieved at
2026-09-09T23:46:31.496840+00:00
publication date
display
2010 Feb 20
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20100958/
title
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer.

Preserved source evidence · Not medical advice